Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Net Margin (2016 - 2018)

Historic Net Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to 2644.51%.

  • Armata Pharmaceuticals' Net Margin rose 142945100.0% to 2644.51% in Q4 2018 from the same period last year, while for Dec 2018 it was 1469.08%, marking a year-over-year increase of 139873400.0%. This contributed to the annual value of 955.06% for FY2024, which is 32323600.0% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its Net Margin stood at 2644.51% for Q4 2018, which was up 142945100.0% from 529.97% recorded in Q3 2018.
  • In the past 5 years, Armata Pharmaceuticals' Net Margin registered a high of 14070.87% during Q3 2014, and its lowest value of 43181.82% during Q4 2016.
  • Its 5-year average for Net Margin is 5994.36%, with a median of 2484.38% in 2015.
  • Per our database at Business Quant, Armata Pharmaceuticals' Net Margin skyrocketed by 2000000000bps in 2014 and then crashed by -406974400bps in 2016.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Net Margin stood at 984.16% in 2014, then tumbled by -152bps to 2484.38% in 2015, then plummeted by -1638bps to 43181.82% in 2016, then skyrocketed by 73bps to 11650.0% in 2017, then soared by 123bps to 2644.51% in 2018.
  • Its Net Margin stands at 2644.51% for Q4 2018, versus 529.97% for Q3 2018 and 1085.41% for Q2 2018.